全文获取类型
收费全文 | 7511篇 |
免费 | 583篇 |
国内免费 | 19篇 |
专业分类
耳鼻咽喉 | 73篇 |
儿科学 | 240篇 |
妇产科学 | 135篇 |
基础医学 | 1194篇 |
口腔科学 | 195篇 |
临床医学 | 841篇 |
内科学 | 1478篇 |
皮肤病学 | 101篇 |
神经病学 | 690篇 |
特种医学 | 416篇 |
外科学 | 828篇 |
综合类 | 39篇 |
一般理论 | 3篇 |
预防医学 | 481篇 |
眼科学 | 81篇 |
药学 | 764篇 |
中国医学 | 8篇 |
肿瘤学 | 546篇 |
出版年
2023年 | 60篇 |
2022年 | 88篇 |
2021年 | 172篇 |
2020年 | 124篇 |
2019年 | 147篇 |
2018年 | 154篇 |
2017年 | 126篇 |
2016年 | 192篇 |
2015年 | 196篇 |
2014年 | 237篇 |
2013年 | 344篇 |
2012年 | 446篇 |
2011年 | 468篇 |
2010年 | 261篇 |
2009年 | 197篇 |
2008年 | 421篇 |
2007年 | 411篇 |
2006年 | 389篇 |
2005年 | 370篇 |
2004年 | 329篇 |
2003年 | 292篇 |
2002年 | 327篇 |
2001年 | 219篇 |
2000年 | 206篇 |
1999年 | 183篇 |
1998年 | 91篇 |
1997年 | 78篇 |
1996年 | 76篇 |
1995年 | 76篇 |
1994年 | 74篇 |
1993年 | 47篇 |
1992年 | 123篇 |
1991年 | 102篇 |
1990年 | 100篇 |
1989年 | 83篇 |
1988年 | 83篇 |
1987年 | 70篇 |
1986年 | 69篇 |
1985年 | 61篇 |
1984年 | 56篇 |
1983年 | 39篇 |
1982年 | 44篇 |
1980年 | 24篇 |
1979年 | 44篇 |
1978年 | 35篇 |
1977年 | 35篇 |
1976年 | 34篇 |
1975年 | 36篇 |
1974年 | 29篇 |
1972年 | 27篇 |
排序方式: 共有8113条查询结果,搜索用时 15 毫秒
1.
2.
3.
Torbj?rn Karlsson 《Upsala journal of medical sciences》2015,120(4):257-262
Background. Haemophagocytic lymphohistiocytosis (HLH) is a rare clinical syndrome characterized by fever, hepatosplenomegaly, cytopenia, and progressive multiple-organ failure. HLH in adults is often secondary to autoimmune diseases, cancer, or infections in contrast to familial HLH. Treatment of secondary HLH is directed against the triggering disease in addition to immunosuppressive therapy, the latter commonly according to the HLH-2004 protocol.Methods. We conducted a retrospective study to identify triggering diseases, disease-specific and immunosuppressive therapy administered, and prognosis in adult patients with secondary HLH. Patient data were collected from October 2010 to January 2015.Results. Ten adult patients with secondary HLH were identified. Seven were men, and the median age at diagnosis was 62 years. Five cases were triggered by malignant disease and five by infection. The median patient fulfilled five of the eight HLH-2004 diagnostic criteria. All patients fulfilled the criteria fever, cytopenia, and ferritin >500 µg/L. Median time from hospital admission to HLH diagnosis was 20 days. Four patients received immunosuppressive therapy according to the HLH-2004 protocol. The prognosis was dismal, especially for the patients with malignancy-associated HLH, of whom all died.Conclusion. HLH should be suspected in patients who present with fever, cytopenia, and ferritin >500 µg/L. Secondary HLH has a dismal prognosis. None of the patients with HLH triggered by malignancy survived. Achieving remission of the triggering disease seems to be important for a favourable outcome as, in all surviving patients, the haemophagocytic syndrome resolved after remission of the underlying infection. 相似文献
4.
5.
Oliver Sartor MD Daniel Heinrich MD Neil Mariados MD Maria José Méndez Vidal MD Daniel Keizman MD Camilla Thellenberg Karlsson MD Avivit Peer MD Giuseppe Procopio MD Stephen J. Frank MD Kalevi Pulkkanen MD Eli Rosenbaum MD Stefano Severi MD José Trigo MD Lucia Trandafir MD Volker Wagner MD Rui Li MS Luke T. Nordquist MD 《The Prostate》2019,79(14):1683-1691
6.
7.
8.
Sergue? O Fetissov Jarmila Hallman Ida Nilsson Ann-Kari Lefvert Lars Oreland Tomas H?kfelt 《Neuropsychopharmacology》2006,60(8):799-802
BACKGROUND: Altered stress response is characteristic for subjects with abnormal aggressive and antisocial behavior, but the underlying biological mechanisms are unclear. We hypothesized that autoantibodies (autoAbs) directed against several stress-related neurohormones may exist in aggressive subjects. METHODS: Using enzyme-linked immunosorbent assay, we studied whether autoAbs directed against corticotropin (ACTH), alpha-melanocyte-stimulating hormone (alpha-MSH), oxytocin, and vasopressin are present in serum of male subjects with conduct disorder and prisoners with history of violence. Healthy blood donors served as control subjects. RESULTS: Both conduct disorder and prisoners groups displayed strongly increased levels of ACTH-reactive immunoglobulin G (IgG) and immunoglobulin M (IgM) autoAbs compared with control subjects. Levels of oxytocin-reactive IgM autoAbs were slightly increased in both groups of aggressive subjects, whereas levels of vasopressin-reactive IgG and IgM autoAbs were lower only in conduct disorder. No differences in the levels of alpha-MSH-reactive autoAbs were found between aggressive and control subjects. CONCLUSIONS: High levels of ACTH-reactive autoAbs as well as altered levels of oxytocin- and vasopressin-reactive autoAbs found in aggressive subjects may interfere with the neuroendocrine mechanisms of stress and motivated behavior. Our data suggest a new biological mechanism of human aggressive behavior that involves autoAbs directed against several stress-related neurohormones. 相似文献
9.
10.
A Watanabe K Ohizumi M Motomiya K Takeuchi T Yoshida S Ida Y Miura K Nishioka Y Tanno T Takishima 《The Japanese journal of antibiotics》1990,43(8):1392-1401
We evaluated the therapeutic efficacy of miconazole (MCZ, Florid-F inj.), a new antifungal agent for parenteral use, in deep-seated fungal infections of respiratory tract system. A daily dose of 400-1,800 mg of MCZ was given intravenously for 12-38 days (mean: 23.4 days) to 7 patients: 2 patients with pulmonary aspergillosis, 1 patient with bronchial aspergillosis, 1 patient with pulmonary candidiasis and 3 patients with candidemia. One additional patient with pulmonary aspergillosis received three instillations of 20 mg of MCZ into the thoracic cavity. The clinical effects were excellent in 1, good in 4 and poor in 3 patients. The efficacy rate was 100% in 5 cases with respiratory fungal infections but 3 cases with candidemia did not respond well to the treatment. Four strains each of Aspergillus sp. and Candida sp. were identified as causative organisms. Seven of the 8 strains were eradicated by administration of MCZ. Side effects observed were irritation and heat in a leg in 1 patient, hyperlipoidemia in 2 patients and eosinophilia in 1 patient. The adverse reactions disappeared after the completion of the therapy. From the above results, we conclude that MCZ is one of the most useful antifungal agents for parenteral use as a first choice on deep-seated fungal infections in the respiratory tract. 相似文献